Phase II Clinical Trials are a critical step in the drug development process. They are designed to evaluate the safety and efficacy of a drug or medical device in a larger group of people than Phase I trials. The Phase II trial market is a subset of the larger clinical trial market, and is composed of pharmaceutical and biotechnology companies, contract research organizations (CROs), and academic institutions. Phase II trials are typically conducted in multiple countries, and involve a larger number of participants than Phase I trials. They are designed to assess the efficacy of a drug or medical device in a larger population, and to identify any potential side effects. The results of Phase II trials are used to determine whether a drug or medical device should proceed to Phase III trials. Some of the companies in the Phase II trial market include Pfizer, Merck, Novartis, Johnson & Johnson, AstraZeneca, GlaxoSmithKline, Bristol-Myers Squibb, Eli Lilly, and Sanofi. CROs such as Parexel, Quintiles, and Covance also play a significant role in the Phase II trial market. Show Less Read more
ASK A QUESTION
We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.
